Temporal Biomarker Profiles Following Non-Surgical Spinal Cord Concussion

IF 2.4 4区 医学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY
Taylor M. Dickson, Anastasiya Loos, Malaika Amin, Juliana Vivas Lopez, Susan F. Murphy, Pamela J. VandeVord, Kelly C. S. Roballo
{"title":"Temporal Biomarker Profiles Following Non-Surgical Spinal Cord Concussion","authors":"Taylor M. Dickson,&nbsp;Anastasiya Loos,&nbsp;Malaika Amin,&nbsp;Juliana Vivas Lopez,&nbsp;Susan F. Murphy,&nbsp;Pamela J. VandeVord,&nbsp;Kelly C. S. Roballo","doi":"10.1007/s12031-026-02520-1","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Traumatic spinal cord concussion (SCC) can result from motor vehicle accidents, contact sports, falls, and other mild traumatic events. Although clinically significant, the relationship between SCC severity and long‑term outcomes remains unclear. Identifying biochemical biomarkers that reflect post‑injury physiological and molecular changes may improve assessment and guide therapeutic decisions. Similar to advances in traumatic brain injury, integrating biomarkers with imaging and behavioral evaluations could enhance SCC characterization. This study examined biomarkers linked to neuroinflammation and repair mechanisms, ubiquitin C‑terminal hydrolase L1 (UCH‑L1), nitric oxide (NO), glial fibrillary acidic protein (GFAP), and brain‑derived neurotrophic factor (BDNF), and characterized their temporal profiles in a preclinical SCC model. Male Sprague–Dawley rats were assigned to either a blast‑induced SCC group or a sham group. Animals were euthanized at 24 h, 72 h, or 6 weeks post‑injury for spinal cord culture preparation and blood collection. UCH‑L1 and other neuronal injury markers remained elevated from the acute through chronic phases in spinal cord cultures and ex vivo serum, indicating neuronal damage. NO displayed a biphasic pattern with an early increase at 24 h, a decrease at 72 h, and renewed elevation at six weeks, suggestive of inflammatory and oxidative stress responses. GFAP levels rose progressively across all time points, consistent with glial activation. In contrast, BDNF levels showed minimal change, suggesting limited neurotrophic support after SCC. Overall, these biomarker expressions on the SCC cell culture and ex vivo serum indicate an ongoing neuronal stress, chronic inflammation, and glial reactivity. UCH‑L1 appears particularly promising for detecting and monitoring SCC‑related injury, while NO and GFAP offers complementary insight into inflammatory response. Combined with clinical assessments, these biomarkers may improve injury stratification and prediction of long‑term outcomes.</p>\n </div>","PeriodicalId":652,"journal":{"name":"Journal of Molecular Neuroscience","volume":"76 2","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2026-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Molecular Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s12031-026-02520-1","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Traumatic spinal cord concussion (SCC) can result from motor vehicle accidents, contact sports, falls, and other mild traumatic events. Although clinically significant, the relationship between SCC severity and long‑term outcomes remains unclear. Identifying biochemical biomarkers that reflect post‑injury physiological and molecular changes may improve assessment and guide therapeutic decisions. Similar to advances in traumatic brain injury, integrating biomarkers with imaging and behavioral evaluations could enhance SCC characterization. This study examined biomarkers linked to neuroinflammation and repair mechanisms, ubiquitin C‑terminal hydrolase L1 (UCH‑L1), nitric oxide (NO), glial fibrillary acidic protein (GFAP), and brain‑derived neurotrophic factor (BDNF), and characterized their temporal profiles in a preclinical SCC model. Male Sprague–Dawley rats were assigned to either a blast‑induced SCC group or a sham group. Animals were euthanized at 24 h, 72 h, or 6 weeks post‑injury for spinal cord culture preparation and blood collection. UCH‑L1 and other neuronal injury markers remained elevated from the acute through chronic phases in spinal cord cultures and ex vivo serum, indicating neuronal damage. NO displayed a biphasic pattern with an early increase at 24 h, a decrease at 72 h, and renewed elevation at six weeks, suggestive of inflammatory and oxidative stress responses. GFAP levels rose progressively across all time points, consistent with glial activation. In contrast, BDNF levels showed minimal change, suggesting limited neurotrophic support after SCC. Overall, these biomarker expressions on the SCC cell culture and ex vivo serum indicate an ongoing neuronal stress, chronic inflammation, and glial reactivity. UCH‑L1 appears particularly promising for detecting and monitoring SCC‑related injury, while NO and GFAP offers complementary insight into inflammatory response. Combined with clinical assessments, these biomarkers may improve injury stratification and prediction of long‑term outcomes.

非手术脊髓脑震荡后的时间生物标志物分析。
创伤性脊髓脑震荡(SCC)可由机动车事故、接触性运动、跌倒和其他轻度创伤事件引起。尽管具有临床意义,但SCC严重程度与长期预后之间的关系尚不清楚。识别反映损伤后生理和分子变化的生化生物标志物可以改善评估和指导治疗决策。与创伤性脑损伤的进展类似,将生物标志物与成像和行为评估相结合可以增强SCC的表征。本研究检测了与神经炎症和修复机制相关的生物标志物,泛素C端水解酶L1 (UCH - L1)、一氧化氮(NO)、胶质纤维酸性蛋白(GFAP)和脑源性神经营养因子(BDNF),并在临床前SCC模型中表征了它们的时间谱。雄性Sprague-Dawley大鼠被分配到爆炸诱导的SCC组或假组。分别于损伤后24小时、72小时或6周对动物实施安乐死,进行脊髓培养准备和采血。在脊髓培养物和离体血清中,UCH‑L1和其他神经元损伤标志物从急性期到慢性期都保持升高,表明神经元损伤。NO表现为双相模式,24小时早期升高,72小时降低,6周时再次升高,提示炎症和氧化应激反应。GFAP水平在所有时间点逐渐上升,与神经胶质激活一致。相比之下,BDNF水平变化很小,提示SCC后神经营养支持有限。总的来说,SCC细胞培养和离体血清中的这些生物标志物表达表明持续的神经元应激、慢性炎症和胶质反应性。UCH - L1似乎特别有希望检测和监测SCC相关损伤,而NO和GFAP提供了对炎症反应的补充见解。结合临床评估,这些生物标志物可以改善损伤分层和长期预后的预测。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Molecular Neuroscience
Journal of Molecular Neuroscience 医学-神经科学
CiteScore
6.60
自引率
3.20%
发文量
142
审稿时长
1 months
期刊介绍: The Journal of Molecular Neuroscience is committed to the rapid publication of original findings that increase our understanding of the molecular structure, function, and development of the nervous system. The criteria for acceptance of manuscripts will be scientific excellence, originality, and relevance to the field of molecular neuroscience. Manuscripts with clinical relevance are especially encouraged since the journal seeks to provide a means for accelerating the progression of basic research findings toward clinical utilization. All experiments described in the Journal of Molecular Neuroscience that involve the use of animal or human subjects must have been approved by the appropriate institutional review committee and conform to accepted ethical standards.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书